Skip to content

Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory Failure

Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04411368
Enrollment
540
Registered
2020-06-02
Start date
2020-06-01
Completion date
2023-12-31
Last updated
2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome, Acute Respiratory Failure

Brief summary

This is an observational study to evaluate the clinical impact of respiratory virus in the patients with acute respiratory failure

Interventions

None listed

Sponsors

Seoul St. Mary's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female aged ≥ 19 years * Written informed consent by the patient or legally authorized representative * Critical illness consistent with acute respiratory failure, to be enrolled within 24 hours of presentation

Exclusion criteria

* No informed consent * A patient who is judged to be unable to make a voluntary decision by understanding information about this research due to cognitive vulnerability

Design outcomes

Primary

MeasureTime frameDescription
Rate of respiratory viral infectionswithin 24 hours after intensive care unit (ICU) admissionRate of respiratory viral infections in patients with acute respiratory failure

Secondary

MeasureTime frameDescription
ICU mortality rateThrough study completion, an average of 1 yearAssociation between respiratory viral infections and death in ICU and risk factors of death in patients with ARF
Hospital mortality rateThrough study completion, an average of 1 yearAssociation between respiratory viral infections and death in hospital and risk factors of death in patients with ARF

Countries

South Korea

Contacts

Primary ContactJongmin Lee, Ph.D
dibs03@gmail.com+821063007128

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026